tiprankstipranks
Trending News
More News >
Regeneron Pharmaceuticals (REGN)
NASDAQ:REGN
US Market

Regeneron (REGN) Income Statement

Compare
5,158 Followers

Regeneron Income Statement

Last quarter (Q4 2025), Regeneron's total revenue was $3.88B, an increase of 2.51% from the same quarter last year. In Q4, Regeneron's net income was $844.60M. See Regeneron’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.34B$ 14.20B$ 13.12B$ 12.17B$ 16.07B
Gross Profit
$ 12.24B$ 12.23B$ 10.87B$ 10.47B$ 13.35B
Operating Expenses
$ 8.66B$ 8.24B$ 6.52B$ 5.08B$ 4.40B
Depreciation and Amortization
$ 543.70M$ 482.90M$ 421.00M$ 341.40M$ 286.20M
EBITDA
$ 5.82B$ 5.32B$ 4.69B$ 5.26B$ 9.67B
Operating Income
$ 3.58B$ 3.99B$ 4.35B$ 5.39B$ 8.95B
Other Income/Expenses
$ 1.65B$ 789.20M$ -149.30M$ -526.80M$ 379.00M
Pretax Income
$ 5.23B$ 4.78B$ 4.20B$ 4.86B$ 9.33B
Net Income
$ 4.50B$ 4.41B$ 3.95B$ 4.34B$ 8.08B
Per Share Metrics
Basic EPS
$ 43.07$ 40.90$ 37.05$ 40.51$ 76.40
Diluted EPS
$ 41.48$ 38.34$ 34.77$ 38.22$ 71.97
Weighted Average Shares Outstanding
104.60M 107.90M 106.70M 107.10M 105.70M
Weighted Average Shares Outstanding (Diluted)
108.60M 115.10M 113.70M 113.50M 112.20M
Currency in USD

Regeneron Earnings and Revenue History